Oculis Holding AG (OCS) stock
OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
$7.51−0.12 (-1.57%)
Close on Nov 17, 2026Market cap $451.27MP/E –Yield –
Oculis operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -CHF 66.30M. The highest annual figure on record is -CHF 12.03M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -CHF 66.30M | – |
| FY2024 | Dec 31, 2024 | -CHF 48.92M | – |
| FY2023 | Dec 31, 2023 | -CHF 55.04M | – |
| FY2022 | Dec 31, 2022 | -CHF 25.07M | – |
| FY2021 | Dec 31, 2021 | -CHF 13.83M | – |
| FY2020 | Dec 31, 2020 | -CHF 12.03M | – |
See a number that looks wrong?